1-7 of 7
Caroline Rousseau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hepatitis B Virus (HBV) Screening and Associated Outcomes in Malignant Hematology Patients Receiving Rituximab Therapy within the Rossy Cancer Network

Shen Li, MD, Allaa Ali, MPH, Alexander Lawandi, MD BS, BA, MSc, Myriam Fernandez, RN, Caroline Rousseau, PhD, Doneal Thomas, M.Phil, M.Sc, Sarit Assouline, Chantal Cassis, MD, Todd Campbell Lee, MD MPH, Kelly L. Davison, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2256.
https://doi.org/10.1182/blood-2018-99-119079
Published: 2018
Journal Articles

Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

Clinical Trials & Observations
Sarit E. Assouline, Torsten Holm Nielsen, Stephen Yu, Miguel Alcaide, Lauren Chong, David MacDonald, Axel Tosikyan, Vishal Kukreti, Abbas Kezouh, Tina Petrogiannis-Haliotis, Marco Albuquerque, Daniel Fornika, Sepideh Alamouti, Remi Froment, Celia M. T. Greenwood, Kathleen Klein Oros, Errol Camglioglu, Ayushi Sharma, Rosa Christodoulopoulos, Caroline Rousseau, Nathalie Johnson, Michael Crump, Ryan D. Morin, Koren K. Mann
Journal: Blood
Blood (2016) 128 (2): 185–194.
https://doi.org/10.1182/blood-2016-02-699520
Published: 2016
Includes: Supplemental data
Journal Articles

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Sarit E. Assouline, MD, Eftihia Cocolakis, PhD, Caroline Rousseau, PhD, Biljana Culjkovic, PhD, Nathalie Beslu, PhD, Abdellatif Amri, Stephen N. Caplan, MD, Brian Leber, MD, Denis-Claude Roy, MD, Katherine L. B. Borden, PhD, Wilson H. Miller, Jr., MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2085.
https://doi.org/10.1182/blood.V114.22.2085.2085
Published: 2009
Journal Articles

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Brief Report
Sarit Assouline, Biljana Culjkovic, Eftihia Cocolakis, Caroline Rousseau, Nathalie Beslu, Abdellatif Amri, Stephen Caplan, Brian Leber, Denis-Claude Roy, Wilson H. Miller, Jr, Katherine L. B. Borden
Journal: Blood
Blood (2009) 114 (2): 257–260.
https://doi.org/10.1182/blood-2009-02-205153
Published: 2009
Includes: Supplemental data
Journal Articles

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

Clinical Trials & Observations
Guillermo Garcia-Manero, Sarit Assouline, Jorge Cortes, Zeev Estrov, Hagop Kantarjian, Hui Yang, Willie M. Newsome, Wilson H. Miller, Jr, Caroline Rousseau, Ann Kalita, Claire Bonfils, Marja Dubay, Tracy-Ann Patterson, Zuomei Li, Jeffrey M. Besterman, Gregory Reid, Eric Laille, Robert E. Martell, Mark Minden
Journal: Blood
Blood (2008) 112 (4): 981–989.
https://doi.org/10.1182/blood-2007-10-115873
Published: 2008
Includes: Supplemental data
Journal Articles

FDG-PET Predicts Response to Fractionated Radioimmunotherapy with 90 Y-Epratuzumab Anti-CD22 MAB in Patients with NHL.

Caroline Bodet-Milin, Caroline Rousseau, Loic Campion, Catherine Ansquer, Benoit Dupas, Noel Milpied, Beatrice Mahe, Jean-Francois Chatal, William A. Wegener, David M. Goldenberg, Francois Kraeber-Bodere
Journal: Blood
Blood (2005) 106 (11): 4782.
https://doi.org/10.1182/blood.V106.11.4782.4782
Published: 2005
Journal Articles

Synergy between all- trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells

Michael Witcher, Douglas T. Ross, Caroline Rousseau, Leslie Deluca, Wilson H. Miller, Jr
Journal: Blood
Blood (2003) 102 (1): 237–245.
https://doi.org/10.1182/blood-2002-09-2725
Published: 2003